Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hofer AC"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Delacher M; Chair for Immunology, Regensburg University, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Regensburg Center for Interventional Immunology (RCI), Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Barra MM; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Herzig Y; Department of Immunology, Weizmann Institute of Science, 234 Herzl Street, 76100 Rehovot, Israel., Eichelbaum K; European Molecular Biology Laboratory, Meyerhofstraße 1, 69117 Heidelberg, Germany., Rafiee MR; European Molecular Biology Laboratory, Meyerhofstraße 1, 69117 Heidelberg, Germany., Richards DM; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Träger U; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hofer AC; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Kazakov A; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Braband KL; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Gonzalez M; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Wöhrl L; Regensburg Center for Interventional Immunology (RCI), Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Schambeck K; Regensburg Center for Interventional Immunology (RCI), Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany., Imbusch CD; Faculty of Biosciences, Heidelberg University, Im Neuenheimer Feld 234, 69120 Heidelberg, Germany; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany., Abramson J; Department of Immunology, Weizmann Institute of Science, 234 Herzl Street, 76100 Rehovot, Israel., Krijgsveld J; European Molecular Biology Laboratory, Meyerhofstraße 1, 69117 Heidelberg, Germany; Proteomics of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany; Medical Faculty, Heidelberg University, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany., Feuerer M; Chair for Immunology, Regensburg University, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Regensburg Center for Interventional Immunology (RCI), Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Electronic address: markus.feuerer@ukr.de.
Publikováno v:
IScience [iScience] 2020 May 22; Vol. 23 (5), pp. 101127. Date of Electronic Publication: 2020 May 04.
Autor:
Delacher M; Chair for Immunology, University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Schmidl C; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Herzig Y; Department of Immunology, Weizmann Institute of Science, 234 Herzl Street, 76100, Rehovot, Israel., Breloer M; Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Straße 74, 20359, Hamburg, Germany., Hartmann W; Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Straße 74, 20359, Hamburg, Germany., Brunk F; Division of Developmental Immunology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Kägebein D; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Träger U; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hofer AC; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Bittner S; Chair for Immunology, University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Weichenhan D; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hotz-Wagenblatt A; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hielscher T; Division of Biostatistics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Breiling A; Division of Epigenetics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Federico G; Division of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Gröne HJ; Division of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Schmid RM; Department of Internal Medicine, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany., Rehli M; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany.; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany., Abramson J; Department of Immunology, Weizmann Institute of Science, 234 Herzl Street, 76100, Rehovot, Israel., Feuerer M; Chair for Immunology, University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. markus.feuerer@ukr.de.; Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. markus.feuerer@ukr.de.; Immune Tolerance Group, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. markus.feuerer@ukr.de.
Publikováno v:
Nature communications [Nat Commun] 2019 Apr 08; Vol. 10 (1), pp. 1621. Date of Electronic Publication: 2019 Apr 08.
Autor:
Delacher M, Imbusch CD, Weichenhan D, Breiling A, Hotz-Wagenblatt A, Träger U, Hofer AC, Kägebein D, Wang Q, Frauhammer F, Mallm JP, Bauer K, Herrmann C, Lang PA, Brors B, Plass C, Feuerer M
Publikováno v:
Nature immunology [Nat Immunol] 2017 Nov 16; Vol. 18 (12), pp. 1361.
Autor:
Delacher M; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Weichenhan D; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Breiling A; Division of Epigenetics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hotz-Wagenblatt A; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany., Träger U; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hofer AC; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kägebein D; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wang Q; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Frauhammer F; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mallm JP; Research Group Genome Organization &Function, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany., Bauer K; Heidelberg Center for Personalized Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg, Germany., Herrmann C; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Lang PA; Department of Molecular Medicine II, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Plass C; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Feuerer M; Immune Tolerance Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Immunology, Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Regensburg, Germany.
Publikováno v:
Nature immunology [Nat Immunol] 2017 Oct; Vol. 18 (10), pp. 1160-1172. Date of Electronic Publication: 2017 Aug 07.
Autor:
Sonner JK; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany., Deumelandt K; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany., Ott M; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany., Thomé CM; DKTK CCU Neurooncology, DKFZ , Heidelberg, Germany., Rauschenbach KJ; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ , Heidelberg, Germany., Schulz S; Centre for Applied Research 'Applied Biomedical Mass Spectrometry' (ABIMAS), Hochschule Mannheim , Mannheim, Germany., Munteanu B; Centre for Applied Research 'Applied Biomedical Mass Spectrometry' (ABIMAS), Hochschule Mannheim , Mannheim, Germany., Mohapatra S; Junior Group Brain Cancer Metabolism, DKFZ , Heidelberg, Germany., Adam I; Junior Group Brain Cancer Metabolism, DKFZ , Heidelberg, Germany., Hofer AC; Research Group Immune Tolerance, DKFZ , Heidelberg, Germany., Feuerer M; Research Group Immune Tolerance, DKFZ , Heidelberg, Germany., Opitz CA; Junior Group Brain Cancer Metabolism, DKFZ, Heidelberg, Germany; Department of Neurology and National Center of Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Hopf C; Centre for Applied Research 'Applied Biomedical Mass Spectrometry' (ABIMAS), Hochschule Mannheim , Mannheim, Germany., Wick W; DKTK CCU Neurooncology, DKFZ, Heidelberg, Germany; Department of Neurology and National Center of Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Platten M; DKTK CCU Neuroimmunology and Brain Tumor Immunology, DKFZ, Heidelberg, Germany; Department of Neurology and National Center of Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Department of Neurology, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 Nov 15; Vol. 5 (12), pp. e1240858. Date of Electronic Publication: 2016 Nov 15 (Print Publication: 2016).
Autor:
Barra MM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Richards DM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Hansson J; Genome Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany., Hofer AC; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Delacher M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Hettinger J; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Krijgsveld J; Genome Biology Unit, European Molecular Biology Laboratory, 69117 Heidelberg, Germany., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and m.feuerer@dkfz-heidelberg.de.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Oct 01; Vol. 195 (7), pp. 3058-70. Date of Electronic Publication: 2015 Aug 31.
The Contained Self-Reactive Peripheral T Cell Repertoire: Size, Diversity, and Cellular Composition.
Autor:
Richards DM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Ruggiero E; Division of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases, 69120 Heidelberg, Germany., Hofer AC; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Sefrin JP; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and., Schmidt M; Division of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases, 69120 Heidelberg, Germany., von Kalle C; Division of Translational Oncology, German Cancer Research Center and National Center for Tumor Diseases, 69120 Heidelberg, Germany., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center, 69120 Heidelberg, Germany; and m.feuerer@dkfz-heidelberg.de.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Sep 01; Vol. 195 (5), pp. 2067-79. Date of Electronic Publication: 2015 Jul 20.
Autor:
Barra MM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Richards DM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hofer AC; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Delacher M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Publikováno v:
PloS one [PLoS One] 2015 May 15; Vol. 10 (5), pp. e0127038. Date of Electronic Publication: 2015 May 15 (Print Publication: 2015).
Autor:
Richards DM; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Delacher M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Goldfarb Y; Faculty of Biology, Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Kägebein D; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hofer AC; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Abramson J; Faculty of Biology, Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Feuerer M; Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: m.feuerer@dkfz.de.
Publikováno v:
Progress in molecular biology and translational science [Prog Mol Biol Transl Sci] 2015; Vol. 136, pp. 175-205. Date of Electronic Publication: 2015 Aug 18.